Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP1VB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on February 4, 2026, with completion expected by February 26, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the awardee's corporate office location in Conshohocken, Pennsylvania. Vyndamax is a specialty pharmaceutical used in the treatment of transthyretin amyloidosis, representing the type of specialized medical commodity that DLA procures to support military healthcare systems and veteran services across the globe.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical supply vehicle extending through December 2031. The IDC enables DLA to efficiently procure a broad spectrum of pharmaceutical products and medical supplies—including specialty medications, generic and brand-name drugs, vaccines, and related medical commodities—to support military treatment facilities and federal healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen consistently competes on a full and open basis for federal medical procurement requirements, demonstrating its established capability to fulfill complex and time-sensitive government pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26FP1VB?
SPE2DR26FP1VB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FP1VB worth?
The government has obligated $14,593 on SPE2DR26FP1VB.
Is contract SPE2DR26FP1VB an order under another contract?
Yes. SPE2DR26FP1VB is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1VB competed?
The extent of competition for SPE2DR26FP1VB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award